Table 2. Hematologic parameters of young patients with sickle/beta-thalassemia at study entry and exit for patients who completed 24 months of hydroxyurea therapy (n: 12).

SD: standard deviation, HU: hydroxyurea, N: number of participants, Hb: hemoglobin, HbF: hemoglobin F, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, WBC: white blood cell count, PLT: platelet count, RETIC: reticulocyte count, LDH: lactate dehydrogenase.